HeartBeam, Inc. (NASDAQ:BEAT) Q2 2022 Earnings Conference Call August 11, 2022 4:30 PM ET
Company Participants
Branislav Vajdic - Chief Executive Officer & Founder
Jon Hunt - Chief Business Officer
Rick Brounstein - Chief Financial Officer
Conference Call Participants
Bill Sutherland - The Benchmark Company
Jason Kolbert - Dawson James
Operator
Greetings and welcome to the HeartBeam Second Quarter 2022 Financial Results Conference Call. At this time, all participants will be in a listen-only mode. A question-and-answer session will follow the formal presentation. As a reminder, this conference is being recorded.
Before we begin the formal presentation, I would like to remind everyone that statements made on the call and webcast may include predictions, estimates, or other information that might be considered forward-looking. While these forward-looking statements represent our current judgment on what the future holds, they are subject to page two of six to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect our opinions only as of the date of this presentation.
Please keep in mind that we are not obligating ourselves to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events.
Throughout today's discussion, we will attempt to present some important factors relating to our business that may affect our predictions. You should also review our most recent Form 10-K and Form 10-Q for a more complete discussion of these factors and other risks, particularly under the heading Risk Factors.
A press release detailing these results crossed the wires this afternoon at 4:01 P.M. Eastern Time and is available in the Investor Relations section of our company's website, heartbeam.com.
Your host today are Branislav Vajdic, Chief Executive Officer and Founder; Jon Hunt, Chief Business Officer; and Rick Brounstein, Chief Financial Officer, will present results of operations for the second quarter ended June 30th, 2022.
At this time, I will turn the call over to HeartBeam Chief Executive Officer, Branislav Vajdic.
Branislav Vajdic
Thank you, operator, and good afternoon, everyone. I'm pleased to welcome you to today's second quarter 2022 financial results conference call. Our second quarter was highlighted by steady increment [ph] along our commercialization pathway, including the upcoming submission of our emerging -- product now called AIMI to the FDA on or about August 15th. We continue to make registering [ph] our second product, the telemedicine platform, now called AIMIGo prepared for FDA submission in Q4 of this year.